# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-048169
Filing Date
2020-10-28
Accepted
2020-10-28 08:08:40
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | crsp-10q_20200930.htm iXBRL | 10-Q | 2335006
2 | EX-31.1 | crsp-ex311_9.htm | EX-31.1 | 18970
3 | EX-31.2 | crsp-ex312_7.htm | EX-31.2 | 19174
4 | EX-32.1 | crsp-ex321_8.htm | EX-32.1 | 8207
| Complete submission text file | 0001564590-20-048169.txt |  | 8634967

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | crsp-20200930.xsd | EX-101.SCH | 57763
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | crsp-20200930_cal.xml | EX-101.CAL | 55654
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | crsp-20200930_def.xml | EX-101.DEF | 175560
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | crsp-20200930_lab.xml | EX-101.LAB | 435203
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | crsp-20200930_pre.xml | EX-101.PRE | 319649
10 | EXTRACTED XBRL INSTANCE DOCUMENT | crsp-10q_20200930_htm.xml | XML | 1708932

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 201266258
SIC: 2836 Biological Products, (No Diagnostic Substances)